Picture of blood cells

Open Access research which pushes advances in bionanotechnology

Strathprints makes available scholarly Open Access content by researchers in the Strathclyde Institute of Pharmacy & Biomedical Sciences (SIPBS) , based within the Faculty of Science.

SIPBS is a major research centre in Scotland focusing on 'new medicines', 'better medicines' and 'better use of medicines'. This includes the exploration of nanoparticles and nanomedicines within the wider research agenda of bionanotechnology, in which the tools of nanotechnology are applied to solve biological problems. At SIPBS multidisciplinary approaches are also pursued to improve bioscience understanding of novel therapeutic targets with the aim of developing therapeutic interventions and the investigation, development and manufacture of drug substances and products.

Explore the Open Access research of SIPBS. Or explore all of Strathclyde's Open Access research...

Browse by Author or Creator

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Publication Date | Item type | No Grouping
Number of items: 11.

Barclay, Zoë and Dickson, Louise and Robertson, Derek N and Johnson, Melanie S and Holland, Pamela J and Rosie, Roberta and Sun, Liting and Fleetwood-Walker, Sue and Lutz, Eve M and Mitchell, Rory (2011) 5-HT2A receptor signalling through phospholipase D1 associated with its C-terminal tail. Biochemical Journal, 436 (3). pp. 651-60.

Lutz, Eve M. and Monaghan, Thomas K. and Pou, Chantevy and Plevin, Robin and MacKenzie, Christopher J. (2010) LIF-mediated maintenance of PACAP-induced neurite outgrowths in human SH-SY5Y neuroblastoma cells require PI3K but not STAT or ERK signaling pathways. Journal of Molecular Neuroscience, 42 (3). p. 297. ISSN 0895-8696

May, Victor and Lutz, E. and MacKenzie, C. and Schutz, Kirstin C. and Dozark, Kate and Braas, Karen M. (2010) Pituitary adenylate cyclase activating polypeptide (PACAP)/PAC1-HOP1 receptor activation coordinates multiple neurotrophic signaling pathways: Akt activation through PI3K and vesicle endocytosis for neuronal survival. Journal of Biological Chemistry, 285 (13). pp. 9749-9761. ISSN 1083-351X

Lutz, Eve and Pou, C. and Monaghan, T.K. and MacKenzie, C.J. (2009) Pituitary adenylate cyclase-activating polypeptide. In: Bioactive Peptides. CRC Press. ISBN 978-1-4200-6114-7

Monaghan, T.K. and Pou, C. and MacKenzie, C.J. and Plevin, R. and Lutz, E. M. (2008) Neurotrophic actions of PACAP and LIF on human neuroblastoma SH-SY5Y cells. Journal of Molecular Neuroscience, 36 (1-3). pp. 45-56. ISSN 0895-8696

Monaghan, T.K. and MacKenzie, C.J. and Plevin, R.J. and Lutz, E. (2008) PACAP-38 induces neuronal differentiation of human SH-SY5Y neuroblastoma cells via cAMP-mediated activation of ERK and p38 MAP kinases. Journal of Neurochemistry, 104 (1). pp. 74-88. ISSN 0022-3042

Lutz, E.M. and Ronaldson, E. and Shaw, P. and Johnson, M.S. and Holland, P.J. and Mitchell, R. (2006) Characterization of novel splice variants of the PAC(1) receptor in human neuroblastoma cells : consequences for signaling by VIP and PACAP. Molecular and Cellular Neuroscience, 31 (2). pp. 193-209.

Grant, S. and Lutz, E.M. and McPhaden, A.R. and Wadsworth, R.M. (2006) Location and function of VPAC(1), VPAC(2) and NPR-C receptors in VIP-induced vasodilation of porcine basilar arteries. Journal of Cerebral Blood Flow and Metabolism, 26 (1). pp. 58-67. ISSN 0271-678X

Mitchell, R. and Robertson, D.N. and Holland, P.J. and Collins, D. and Lutz, E.M. and Johnson, M.S. (2003) ADP-ribosylation factor-dependent phospholipase D activation by the M-3 muscarinic receptor. Journal of Biological Chemistry, 278 (36). pp. 33818-33830. ISSN 1083-351X

Robertson, D.N. and Johnson, M.S. and Moggach, L.O. and Holland, P.J. and Lutz, E. and Mitchell, R. (2003) Selective interaction of ARF 1 with the carboxy-terminal tail domain of the 5-HT2A receptor. Molecular Pharmacology, 64. pp. 1239-1250. ISSN 0026-895X

MacKenzie, C. and Lutz, E. and Johnson, M.S. and Robertson, D.N. and Holland, P.J. and Mitchell, R. (2001) Mechanisms of phospholipase C activation by the vasoactive intestinal polypeptide/pituitary adenylate cyclase activating polypeptide type 2 receptor. Endocrinology, 142 (3). pp. 1209-1217. ISSN 0013-7227

This list was generated on Thu Jul 18 06:04:00 2019 BST.